EcoDrugPlus

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSBBBG00000021478
Gene Symbol: F2R
1 Cross references
330 Possible Orthologues:

Coagulation Factor Ii, Thrombin

Ensembl ID : ENSBBBG00000002915
Gene Symbol: F2
3 Cross references
86 Possible Orthologues:

Coagulation Factor Iii, Tissue Factor

Ensembl ID : ENSBBBG00000005677
Gene Symbol: F3
3 Cross references
246 Possible Orthologues:

Coagulation Factor Vii

Ensembl ID : ENSBBBG00000019947
Gene Symbol: F7
3 Cross references
203 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSBBBG00000019957
Gene Symbol: F10
3 Cross references
239 Possible Orthologues:

Coagulation Factor Xi

Ensembl ID : ENSBBBG00000003065
Gene Symbol: F11
3 Cross references
215 Possible Orthologues:

Coagulation Factor Xii

Ensembl ID : ENSBBBG00000010768
Gene Symbol: F12
3 Cross references
187 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSBBBG00000011386
Gene Symbol: CCDC6
3 Cross references
223 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSBBBG00000006257
Gene Symbol: CSF1R
3 Cross references
273 Possible Orthologues:

Complement C1s

Ensembl ID : ENSBBBG00000002855
Gene Symbol: C1S
3 Cross references
199 Possible Orthologues:

Complement C5

Ensembl ID : ENSBBBG00000019266
Gene Symbol: C5
3 Cross references
212 Possible Orthologues:

Complement Factor D

Ensembl ID : ENSBBBG00000007086
Gene Symbol: CFD
3 Cross references
134 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).